Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million ...
RMIT University will offer Queensland's first nuclear medicine degree, addressing critical workforce shortages and shoring up cancer services across ...
One Million Patients Led to This Moment PRINCETON, N.J., Nov. /PRNewswire/ -- Bracco Diagnostics Inc., the U.S. subsidiary of B ...
Verdence Capital Advisors LLC lowered its holdings in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 23.3% in the ...
Worldcrunch on MSN1d
Lecanemab: Why This Could Be The Beginning Of The End Of Alzheimer’sThe first drug targeting the root cause of Alzheimer’s disease has been approved by the European Medicines Agency. Despite ...
In October 2024, Immunic, Inc. announced a positive outcome of the non-binding, interim futility analysis of its Phase III ENSURE program, investigating lead asset, nuclear ... resonance imaging (MRI) ...
Ugo Amaldi helped create a European network of cancer therapy centres using beams of ions, in particular carbon ions ...
Over the last 2 decades, significant progress has been made in our understanding of the genomics, tumor immune ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback